Replies to post #8847 on Novavax Inc (NVAX)

[cowtown jay]

It appears to me that it may be Pfizer who has fallen at the feet of Novavax.

From what I can see, this agreement is for the use of Novavax's protein-based technology platform, which is an about-face from Pfizer's focus on mRNA vaccine technology.

"About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies."

https://ir.novavax.com/press-releases/2026-01-20-Novavax-Announces-Entering-into-a-License-Agreement-with-Pfizer

I wonder if Malaria may be one of the targeted indications.